These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 12760190)

  • 1. Antithrombotic therapies for stroke prevention in atrial fibrillation.
    Hart RG
    Adv Neurol; 2003; 92():249-56. PubMed ID: 12760190
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombotic therapies for stroke prevention in atrial fibrillation.
    Economides Muñoz C; Singh BN
    Minerva Cardioangiol; 2004 Apr; 52(2):125-39. PubMed ID: 15194994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].
    Prisco D
    Haematologica; 2001 Sep; 86(9 Suppl):12-3. PubMed ID: 11759618
    [No Abstract]   [Full Text] [Related]  

  • 4. Stroke prevention in atrial fibrillation patients.
    Marinigh R; Lip GY; Lane DA
    Expert Opin Pharmacother; 2010 Oct; 11(14):2331-50. PubMed ID: 20718589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 6. Confronting atrial fibrillation in the elderly: stroke risk stratification and emerging antithrombotic therapies.
    Strong SH; Halperin JL
    Geriatrics; 2007 Mar; 62(3):22-7. PubMed ID: 17346095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke risk assessment for atrial fibrillation: hospital-based stroke risk assessment and intervention program.
    Jackson SL; Peterson GM
    J Clin Pharm Ther; 2011 Feb; 36(1):71-9. PubMed ID: 21198722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic treatment in atrial fibrillation.
    Lip GY; Boos CJ
    Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke prevention in hospitalized patients with atrial fibrillation: a population-based study.
    Nagpal S; Anderson D; Putnam W; Flowerdew G; Gardner M; Cox J
    Can J Clin Pharmacol; 2003; 10(4):197-201. PubMed ID: 14712325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic therapy for stroke prevention in atrial fibrillation.
    Go AS; Fang MC; Singer DE
    Prog Cardiovasc Dis; 2005; 48(2):108-24. PubMed ID: 16253651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New concepts and approaches to stroke prevention in the new European Society of Cardiology guidelines for the management of atrial fibrillation.
    Kuzniatsova N; Lip GY
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1643-7. PubMed ID: 21108546
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticoagulation for atrial fibrillation patients with CHADS score of 1.
    Lane DA; Lip GY
    J Cardiovasc Electrophysiol; 2010 May; 21(5):508-10. PubMed ID: 20082649
    [No Abstract]   [Full Text] [Related]  

  • 13. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation subtypes, risk of stroke, and antithrombotic therapy.
    Stramba-Badiale M
    Eur Heart J; 2008 Apr; 29(7):840-2. PubMed ID: 18334477
    [No Abstract]   [Full Text] [Related]  

  • 15. Reducing the risk for stroke in patients who have atrial fibrillation.
    Garcia DA; Hylek E
    Cardiol Clin; 2008 May; 26(2):267-75, vii. PubMed ID: 18406999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer].
    Mooe T
    Lakartidningen; 2008 Sep 10-16; 105(37):2472-3. PubMed ID: 19006861
    [No Abstract]   [Full Text] [Related]  

  • 17. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of stroke in atrial fibrillation].
    Masjuan J
    Neurologia; 2012 Mar; 27 Suppl 1():1-3. PubMed ID: 22682203
    [No Abstract]   [Full Text] [Related]  

  • 19. New oral anticoagulants in atrial fibrillation.
    Turpie AG
    Eur Heart J; 2008 Jan; 29(2):155-65. PubMed ID: 18096568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Will warfarin soon be passé? New approaches to stroke prevention in atrial fibrillation.
    Hammwöhner M; Goette A
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):18-27. PubMed ID: 18594479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.